Second HERA Invest agreement signed to advance therapies against antimicrobial resistance
HERA has today signed the second agreement under HERA Invest, its pioneering financial mechanism designed to support the research and development of medical countermeasures (MCMs) and technologies to address priority cross-border health threats. Read the news...